Hemoglobin (Hb) level in the range of ≥7 g/dL and \<10 g/dL at screening
Erythropoiesis Stimulating Agent (ESA) naïve subjects or previously treated subjects with ESA-free period of \>3 months (in case of pre-treatment with long-acting ESA such as pegylated epoetin, the long-acting ESA-free period of \>6 months)
You may not be if
Subjects who have received steady dialysis or subjects who are currently on dialysis
Subjects who have rapid progression of chronic renal failure (as per investigators' discretion; e.g., a GFR decrease of \>20% within 12 weeks prior to screening)
Subjects who have already undergone renal transplantation or who are scheduled for renal transplantation
Clareo Health | To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)
